We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Blood Irradiation Indicators Protect from Graft Disease

By HospiMedica International staff writers
Posted on 05 Mar 2012
Improved irradiation indicators can verify quickly and clearly that blood components have been irradiated to protect patients from contracting transfusion-associated graft-versus-host disease (TA-GVHD).

The Rad-Sure is a complex, multilayered laminate device that is affixed to transfusion blood bags. More...
It features a gamma ray or X-ray sensitive indicator that displays a clear "NOT IRRADIATED" message until exposed to the proper level of radiation. Once exposed, the "NOT" becomes obscured and the visual message reads, "IRRADIATED," providing quick, positive, visual verification. The device is easy to use, with the batch number and expiry date printed on every box, as well as on every indicator. A temperature history indicator is included in every box.

Irradiation of red blood cells and whole blood results in reduced post transfusion red cell recovery, and increases the rate of efflux of intracellular potassium. It has no clinically significant effect on red cell pH, glucose, 2,3 diphosphoglycerate (DPG) levels or adenosine triphosphate (ATP). Packs irradiated within 14 days of collection expire 28 days after collection, and packs irradiated more than 14 days after collection expire either 5 days after irradiation or at the original expiry date of the pack, whichever comes first.

In patients where hyperkalaemia is a concern, the red cells should be transfused within 24 hours of irradiation. Additionally, the irradiation of platelets has not been shown to cause any clinically significant change in platelet function. The Rad-Sure device is a product of Ashland (Covington, KY, USA) and is available for both gamma and X-ray irradiation sources.

TA-GVHD is a rare, but potentially fatal, complication associated with blood transfusions in which the blood donor's lymphocytes engraft in the recipient. Certain categories of patients, such as those with solid tumors, acquired T-cell deficiencies and bone marrow transplant recipients, are more prone to contracting the disease. Proper irradiation of the blood before transfusion destroys the donor lymphocytes and prevents the immunoreaction that leads to TA-GVHD.

Related Links:

Ashland



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.